Bharat Biotech ready to share Covaxin formula with companies, Centre invites companies to produce vaccines

[{"selector":"#anim-5eb029e3-78e6-4bd1-86f0-0a369c8a08a9","keyframes":{"transform":["translate3d(0px, 100%, 0)","translate3d(0px, 0px, 0)"]},"delay":350,"direction":"normal","duration":600,"easing":"cubic-bezier(0.445, 0.05, 0.55, 0.95)","fill":"both"}] Bharat Biotech ready to share Covaxin formula with companies, Centre invites companies to produce vaccines

[{"selector":"#anim-7c427121-6795-4682-b847-9a80b8d8ece9","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] [{"selector":"#anim-f8497eba-3669-42a6-83f2-4af5192a3f5d","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] [{"selector":"#anim-ffc7e6f6-681e-483b-a01c-8ecf97fd3626","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] NEWS Bharat Biotech ready to share Covaxin formula with companies, Centre invites companies to produce vaccines By Pallavi Paul Hyderabad based manufacture of Covaxin, Bharat Biotech on 13th May, 2021 declared that they are ready to share the formula and technology of the vaccine with companies who are willing to manufacture the same voluntarily. NITI Aayog member, Dr. V.K Paul while addressing a press conference stated that Covaxin inactivates the live virus but, this vaccine can only be produced in a special lab called BSL3 labs (Biosafety level 3 laboratories) which is very sophisticated and not-available in most of the companies. If the companies who are willing to set up a facility for the local

[{"selector":"#anim-ef91ae8c-ca12-4ac6-ae5f-2f2db4fa94e1","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] [{"selector":"#anim-5471bc3f-e202-4a50-82bb-2de8294403d5","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] [{"selector":"#anim-7db78888-2571-47b8-91f4-03665748dc15","keyframes":{"transform":["translate3d(-100%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"direction":"normal","duration":1000,"easing":"cubic-bezier(0.645, 0.045, 0.355, 1)","fill":"both"}] NEWS By Pallavi Paul production of the vaccine gets support of the Central Government, the availability and production of the vaccines can increase. Further, Dr. Paul informed that Bharat Biotech is committed to increase its vaccine production from 1 crore to 10 crores on its own, but if the same vaccine can be manufactured by four more companies the production can rise up to 50 crores. On hearing this, Indian Immunological Limited, Haffkine Biopharmaceutical Corporation, and Bharat Immunological and Biologicals Corporation Limited declared they will start production of Covaxin by the end of November, 2021. This step comes as a relief to citizens, as India is currently facing the second wave of Covid-19 pandemic and in addition to it is facing shortage of vaccines as well.